Search results
Showing 8071 to 8085 of 8211 results
NICE has today (20 March 2020) announced that it is developing a series of rapid guidelines with NHS England/Improvement on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19, in a number of clinical areas.
NHS England has asked NICE to develop a guideline on the management and follow up of blood clots and low platelet counts associated with COVID-19 vaccination.
Following improved access and optimisation of the website, the NICE guidance app will no longer be available for download with plans to phase it out by January 2019.
NICE to support the NHS in gaining free trial access to medical research
NICE is participating in a pilot trial which aims to support the NHS in gaining free access to the latest high-quality clinical and scientific research.
NICE has published new guidance setting out ‘red flag events’ which warn when nurses in charge of shifts must act immediately to ensure they have enough staff to meet the needs of patients on that ward.
NICE is updating its guideline on Alcohol interventions in secondary and further education.
NICE updates managing COVID guideline with new monoclonal antibody recommendations
NICE has updated its managing COVID-19 guideline to include new recommendations on using monoclonal antibodies to treat COVID-19 patients in hospital.
We have listened to concerns raised by patient groups about the application of our rapid COVID-19 critical care guideline.
NICE has updated its advice on two therapeutics for managing COVID-19 – remdesivir and colchicine.
The long-term safety and efficacy is inadequate on two procedures NICE is calling for further evidence on
Thousands of people asked each year could be missing out on brief interventions to help curb problem drinking, or a potential referral to specialist alcohol services.
NICE is delighted with today’s (15 March) announcement from the Department of Health & Social Care appointing six new non-executive directors to its Board following their approval by the Secretary of State.
NICE’s priority is to get the best care to patients fast while ensuring value for the taxpayer.
Improving the uptake of hepatitis B vaccination among at risk groups, developing tools to make evidence-based medicine more accessible, and carrying out a clinical outcome assessment in hand surgery are just some of the projects planned by the latest group of fellows and scholars.
New Chief Medical Officer, Chief People Officer and Director of Implementation and Partnerships appointed by NICE